Evolv Receives Expected Nasdaq Delinquency Notification
Evolv Technology (NASDAQ: EVLV) has received a delinquency notification from Nasdaq on November 21, 2024, for failing to timely file its Q3 2024 Quarterly Report. The delay stems from an ongoing internal investigation into the company's sales practices, affecting revenue recognition and other metrics. While this notification does not immediately impact Evolv's Nasdaq listing, the company must submit a compliance plan by January 20, 2025. If accepted, Nasdaq may grant an extension until May 19, 2025, to regain compliance. Evolv states it is working to file the report as soon as possible.
Evolv Technology (NASDAQ: EVLV) ha ricevuto una notifica di morosità da Nasdaq il 21 novembre 2024, per non aver presentato in tempo il suo rapporto trimestrale del Q3 2024. Il ritardo è dovuto a un'indagine interna in corso sulle pratiche di vendita dell'azienda, che influisce sul riconoscimento delle entrate e su altri indicatori. Sebbene questa notifica non impatti immediatamente la quotazione di Evolv su Nasdaq, l'azienda deve presentare un piano di conformità entro il 20 gennaio 2025. Se accettato, Nasdaq potrebbe concedere un'estensione fino al 19 maggio 2025 per ripristinare la conformità. Evolv afferma di lavorare per presentare il rapporto il prima possibile.
Evolv Technology (NASDAQ: EVLV) ha recibido una notificación de incumplimiento de Nasdaq el 21 de noviembre de 2024, por no haber presentado a tiempo su Informe Trimestral del Q3 2024. La demora se debe a una investigación interna en curso sobre las prácticas de ventas de la empresa, que afecta el reconocimiento de ingresos y otros métricas. Aunque esta notificación no afecta de inmediato la cotización de Evolv en Nasdaq, la compañía debe presentar un plan de cumplimiento antes del 20 de enero de 2025. Si se acepta, Nasdaq puede conceder una extensión hasta el 19 de mayo de 2025 para recuperar la conformidad. Evolv afirma que está trabajando para presentar el informe lo antes posible.
Evolv Technology (NASDAQ: EVLV)는 2024년 11월 21일에 Nasdaq으로부터 Q3 2024 분기 보고서를 제때 제출하지 못해 연체 통지를 받았습니다. 지체는 회사의 판매 관행에 대한 진행 중인 내부 조사에 기인하며, 이는 수익 인식 및 기타 지표에 영향을 미칩니다. 이 통지는 Evolv의 Nasdaq 상장에 즉시 영향을 미치지 않지만, 회사는 2025년 1월 20일까지 준수 계획을 제출해야 합니다. 만약 수락된다면, Nasdaq은 2025년 5월 19일까지 준수를 회복할 수 있도록 연장을 허용할 수 있습니다. Evolv는 가능한 한 빨리 보고서를 제출하기 위해 노력하고 있다고 밝혔습니다.
Evolv Technology (NASDAQ: EVLV) a reçu une notification de délinquance de Nasdaq le 21 novembre 2024, pour ne pas avoir soumis à temps son Rapport Trimestriel du Q3 2024. Ce retard est dû à une enquête interne en cours concernant les pratiques de vente de l’entreprise, ce qui affecte la reconnaissance des revenus et d'autres indicateurs. Bien que cette notification n'impacte pas immédiatement le listing de Evolv sur Nasdaq, l'entreprise doit soumettre un plan de conformité avant le 20 janvier 2025. Si ce plan est accepté, Nasdaq peut accorder une extension jusqu'au 19 mai 2025 pour retrouver la conformité. Evolv déclare travailler pour soumettre le rapport dès que possible.
Evolv Technology (NASDAQ: EVLV) hat am 21. November 2024 eine Mahnung von Nasdaq erhalten, weil das Unternehmen seinen Quartalsbericht für das dritte Quartal 2024 nicht fristgerecht eingereicht hat. Die Verzögerung resultiert aus einer laufenden internen Untersuchung zu den Verkaufspraktiken des Unternehmens, die die Umsatzrealisierung und andere Kennzahlen beeinflusst. Während diese Mitteilung die Nasdaq-Notierung von Evolv nicht sofort beeinträchtigt, muss das Unternehmen bis zum 20. Januar 2025 einen Compliance-Plan vorlegen. Wenn dieser akzeptiert wird, kann Nasdaq eine Fristverlängerung bis zum 19. Mai 2025 gewähren, um die Compliance wiederherzustellen. Evolv gibt an, dass es daran arbeitet, den Bericht so schnell wie möglich einzureichen.
- None.
- Delayed filing of Q3 2024 Quarterly Report due to internal investigation
- Non-compliance with Nasdaq listing requirements
- Internal investigation reveals issues with sales practices affecting revenue recognition
- Risk of potential Nasdaq delisting if compliance is not achieved
Insights
The Nasdaq delinquency notice for Evolv represents a significant compliance issue stemming from delayed Q3 2024 filings due to an internal investigation into sales practices. The investigation's focus on revenue recognition raises material concerns about financial reporting accuracy and internal controls.
While there's no immediate threat of delisting, the 60-day deadline to submit a compliance plan and potential 180-day grace period create a critical timeline. The underlying sales practice investigation could lead to revenue restatements and impact investor confidence. The company's
Historical patterns show companies facing similar situations often experience increased volatility and institutional selling pressure during the resolution period. The need for investigation into sales practices specifically suggests potential systemic issues that could require significant remediation efforts.
No Immediate Effect on the Company’s Securities Listed on Nasdaq
Nasdaq has informed the Company that it must submit a plan of compliance within 60 calendar days from the date of the Notice, or by January 20, 2025, to address how it intends to regain compliance with the Nasdaq Listing Rule. If accepted, Nasdaq can grant an exception of up to 180 calendar days from the filing's due date as extended by Rule 12b-25, or until May 19, 2025, to regain compliance.
The Company is working diligently to file the Quarterly Report as soon as reasonably practicable.
About Evolv Technology
Evolv Technology (NASDAQ: EVLV) is designed to transform human security to make a safer, faster, and better experience for the world’s most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv’s advanced systems have scanned more than a billion people since 2019. Evolv has been awarded the
Forward-looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend for such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including statements regarding the timing of the filing of the Company’s Quarterly Report and submitting a plan to regain compliance with the Nasdaq Listing Rule. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results and actions to be materially different from any future results or actions expressed or implied by the forward-looking statements, including, but not limited to, the factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission ("SEC") on February 29, 2024, as any such factors may be updated from time to time in our other filings with the SEC, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2024. The forward-looking statements in this press release are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.
Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this press release, whether as a result of any new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241122410187/en/
Media Contact:
Alexandra Smith Ozerkis
aozerkis@evolvtechnology.com
Investor Contact:
Brian Norris
bnorris@evolvtechnology.com
Source: Evolv Technology
FAQ
Why did Evolv Technology (EVLV) receive a Nasdaq delinquency notice?
What is the deadline for Evolv Technology (EVLV) to submit its compliance plan to Nasdaq?